QVANTIG
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97566219
- Registration number
- 7995268
- Mark type
- Stylized text
- Filed
- 26 Aug 2022
- Published for opposition
- 20 Jun 2023
- Registered
- 21 Oct 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of cancer
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Aug 2025 — USE AMENDMENT FILED
- 14 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2025 — SOU EXTENSION 3 GRANTED
- 15 Feb 2025 — SOU EXTENSION 3 FILED
- 07 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 24 Feb 2025 — NOTICE OF REVIVAL - E-MAILED
- 24 Feb 2025 — PETITION TO REVIVE-GRANTED
- 24 Feb 2025 — TEAS PETITION TO REVIVE RECEIVED